Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.
Patent CN118344279B enables metal-free indole synthesis. Reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN108341739B reveals a mild palladium-catalyzed route for alpha-aryl-difluoromethyl compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.
Novel synthesis of Sacubitril intermediate via Cu-catalyzed coupling. Reduces cost, improves yield, scalable process for heart failure drug manufacturing.
Patent CN103408593B reveals a novel pyrimidine-based route for Tenofovir. This method ensures high purity, cost efficiency, and scalable manufacturing for global supply chains.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Advanced purification process reducing moisture and solvent residues for enhanced stability. Ideal for pharmaceutical manufacturing partners seeking high-purity cephalosporin intermediates.
Patent CN103589665A reveals a novel Rhodococcus qingshengii strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.
Patent CN109456249A offers metal-free acid catalysis for Isatin. Reduces cost and improves supply chain reliability for API manufacturing.
Novel polyionic liquid catalyst enhances yield and reduces waste for phenylpyruvic acid production offering supply chain stability and cost efficiency.
Patent CN103373953A reveals a safe, high-yield route for 3-aminopiperidine, offering cost-effective API intermediate manufacturing solutions.
Novel patent CN117486758B offers safe synthesis for neurological drug intermediates. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing without hazardous reagents.
Novel zinc-promoted method for benzindol-5-ols offers mild conditions and high atom economy, ensuring reliable supply chain and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN104803905B reveals high-yield Pd-catalyzed route. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101575315A details new naphthalimide derivatives with superior antitumor activity, offering scalable routes for reliable pharmaceutical intermediate suppliers.
Patent CN119409696B reveals blue-light oxidative dehydrogenation for moxifloxacin side chains, offering greener scale-up and high purity.
Patent CN105087744A details DKR method for high-purity S-5-methyl-1-amino indan. Offers cost reduction in pharma manufacturing and supply chain reliability.
Patent CN104628720A offers high purity moxifloxacin hydrochloride refining. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.